The DOI matches its Crossref record; 326 of the 326 references it cites were found in a registry or an index.
Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee
Abstract
Guidelines for clinical practice are aimed to indicate preferred approaches to medical problems as established by scientifically valid research. Double-blind placebo controlled studies are preferable, but compassionate-use reports and expert review articles are used in a thorough review of the literature conducted through Medline with the National Library of Medicine. When only data that will not withstand objective scrutiny are available, a recommendation is identified as a consensus of experts. Guidelines are applicable to all physicians who address the subject regardless of specialty training or interests and are aimed to indicate the preferable but not necessarily the only acceptable approach to a specific problem. Guidelines are intended to be flexible and must be distinguished from standards of care, which are inflexible and rarely violated. Given the wide range of specifics in any health-care problem, the physician must always choose the course best suited to the individual patient and the variables in existence at the moment of decision. Guidelines are developed under the auspices of the American College of Gastroenterology and its Practice Parameters Committee and approved by the board of trustees. Each has been intensely reviewed and revised by the Committee, other experts in the field, physicians who will use them, and specialists in the science of decision analysis. The recommendations of each guideline are therefore considered valid at the time of composition based on the data available. New developments in medical research and practice pertinent to each guideline will be reviewed at a time established and indicated at publication to assure continued validity. The recommendations made are based on the level of evidence found. Grade A recommendations imply that there is consistent level 1 evidence (randomized controlled trials), grade B indicates that the evidence would be level 2 or 3, which are cohort studies or case-control studies. Grade C recommendations are based on level 4 studies, meaning case series or poor-quality cohort studies, and grade D recommendations are based on level 5 evidence, meaning expert opinion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoporosis Prevention, Diagnosis, and Therapy
NIH Consensus Development Panel on Osteoporosis Prevention, D. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.6.785 · Cited by 5,529
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
Hanauer, S. B., Feagan, B. G., Lichtenstein, G. R., Mayer, L. F., Schreiber, S., Colombel, J. F., Rachmilewitz, D., Wolf, D. C., Olson, A., Bao, W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08512-4 · Cited by 4,169
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
Rutgeerts, P., Sandborn, W. J., Feagan, B. G., Reinisch, W., Olson, A., Johanns, J., Travers, S., Rachmilewitz, D., Hanauer, S. B., Lichtenstein, G. R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050516 · Cited by 3,902
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W. D., Siegel, J. N., & Braun, M. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011110 · Cited by 3,710
Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative Colitis
Schroeder, K. W., Tremaine, W. J., & Ilstrup, D. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198712243172603 · Cited by 3,026
The risk of colorectal cancer in ulcerative colitis: a meta-analysis
Eaden, J. A., Abrams, K. R., & Mayberry, J. F. (2001) · Gut · doi:10.1136/gut.48.4.526 · Cited by 2,959
Cortisone in Ulcerative Colitis
Truelove, S. C., & Witts, L. J. (1955) · BMJ · doi:10.1136/bmj.2.4947.1041 · Cited by 2,767
Bongartz, T., Sutton, A. J., Sweeting, M. J., Buchan, I., Matteson, E. L., & Montori, V. (2006) · JAMA · doi:10.1001/jama.295.19.2275 · Cited by 2,468
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
Baert, F., Noman, M., Vermeire, S., Van Assche, G., D' Haens, G., Carbonez, A., & Rutgeerts, P. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020888 · Cited by 2,015
(2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.167.4.603 · Cited by 1,944
Cited by
Ungaro, R., Mehandru, S., Allen, P. B., Peyrin-Biroulet, L., & Colombel, J.-F. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32126-2 · Cited by 3,531
Silverberg, M. S., Satsangi, J., Ahmad, T., Arnott, I. D., Bernstein, C. N., Brant, S. R., Caprilli, R., Colombel, J.-F., Gasche, C., Geboes, K., et al. (2005) · Canadian Journal of Gastroenterology · doi:10.1155/2005/269076 · Cited by 3,409
Self-citationLamb, C. A., Kennedy, N. A., Raine, T., Hendy, P. A., Smith, P. J., Limdi, J. K., Hayee, B., Lomer, M. C. E., Parkes, G. C., Selinger, C., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318484 · Cited by 2,346
Ordás, I., Eckmann, L., Talamini, M., Baumgart, D. C., & Sandborn, W. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60150-0 · Cited by 2,078
Inflammatory bowel disease: clinical aspects and established and evolving therapies
Baumgart, D. C., & Sandborn, W. J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60751-x · Cited by 1,920
Magro, F., Gionchetti, P., Eliakim, R., Ardizzone, S., Armuzzi, A., Barreiro-de Acosta, M., Burisch, J., Gecse, K. B., Hart, A. L., Hindryckx, P., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjx008 · Cited by 1,910
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
Sandborn, W. J., Su, C., Sands, B. E., D’Haens, G. R., Vermeire, S., Schreiber, S., Danese, S., Feagan, B. G., Reinisch, W., Niezychowski, W., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1606910 · Cited by 1,770
Quality indicators for colonoscopy
Rex, D. K., Schoenfeld, P. S., Cohen, J., Pike, I. M., Adler, D. G., Fennerty, M. B., Lieb, J. G., Park, W. G., Rizk, M. K., Sawhney, M. S., et al. (2015) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2014.07.058 · Cited by 1,764
Quality Indicators for Colonoscopy
Rex, D. K., Schoenfeld, P. S., Cohen, J., Pike, I. M., Adler, D. G., Fennerty, B. M., Lieb, J. G., Park, W. G., Rizk, M. K., Sawhney, M. S., et al. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.385 · Cited by 1,401
D’Haens, G., Sandborn, W. J., Feagan, B. G., Geboes, K., Hanauer, S. B., Irvine, E. J., Lémann, M., Marteau, P., Rutgeerts, P., Schölmerich, J., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.12.038 · Cited by 1,207
Faubion, W. A., Loftus, E. V., Harmsen, W. S., Zinsmeister, A. R., & Sandborn, W. J. (2001) · Gastroenterology · doi:10.1053/gast.2001.26279 · Cited by 1,144
Danese, S., & Fiocchi, C. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1102942 · Cited by 1,102
Panaccione, R., Ghosh, S., Middleton, S., Márquez, J. R., Scott, B. B., Flint, L., van Hoogstraten, H. J. F., Chen, A. C., Zheng, H., Danese, S., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.10.052 · Cited by 963
Frolkis, A. D., Dykeman, J., Negrón, M. E., deBruyn, J., Jette, N., Fiest, K. M., Frolkis, T., Barkema, H. W., Rioux, K. P., Panaccione, R., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.07.041 · Cited by 892
Dignass, A., Eliakim, R., Magro, F., Maaser, C., Chowers, Y., Geboes, K., Mantzaris, G., Reinisch, W., Colombel, J.-F., Vermeire, S., et al. (2012) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2012.09.003 · Cited by 888
Quality Indicators for Colonoscopy
Rex, D. K., Petrini, J. L., Baron, T. H., Chak, A., Cohen, J., Deal, S. E., Hoffman, B., Jacobson, B. C., Mergener, K., Petersen, B. T., et al. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00673.x · Cited by 845
Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
Sandborn, W. J., Ghosh, S., Panes, J., Vranic, I., Su, C., Rousell, S., & Niezychowski, W. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112168 · Cited by 800
Distinct Cytokine Patterns Identified from Multiplex Profiles of Murine DSS and TNBS-Induced Colitis
Alex, P., Zachos, N. C., Nguyen, T., Gonzales, L., Chen, T.-E., Conklin, L. S., Centola, M., & Li, X. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20753 · Cited by 750
Tian, T., Wang, Z., & Zhang, J. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/4535194 · Cited by 714
Evidence-based clinical practice guidelines for inflammatory bowel disease
Matsuoka, K., Kobayashi, T., Ueno, F., Matsui, T., Hirai, F., Inoue, N., Kato, J., Kobayashi, K., Kobayashi, K., Koganei, K., et al. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-018-1439-1 · Cited by 698
Ward, M. M., Deodhar, A., Gensler, L. S., Dubreuil, M., Yu, D., Khan, M. A., Haroon, N., Borenstein, D., Wang, R., Biehl, A., et al. (2019) · Arthritis Care & Research · doi:10.1002/acr.24025 · Cited by 693
Laharie, D., Bourreille, A., Branche, J., Allez, M., Bouhnik, Y., Filippi, J., Zerbib, F., Savoye, G., Nachury, M., Moreau, J., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61084-8 · Cited by 646
A comprehensive review and update on ulcerative colitis,
Gajendran, M., Loganathan, P., Jimenez, G., Catinella, A. P., Ng, N., Umapathy, C., Ziade, N., & Hashash, J. G. (2019) · Disease-a-Month · doi:10.1016/j.disamonth.2019.02.004 · Cited by 638
Ward, M. M., Deodhar, A., Gensler, L. S., Dubreuil, M., Yu, D., Khan, M. A., Haroon, N., Borenstein, D., Wang, R., Biehl, A., et al. (2019) · Arthritis & Rheumatology · doi:10.1002/art.41042 · Cited by 623
Solem, C. A., Loftus, E. V., Tremaine, W. J., Harmsen, W. S., Zinsmeister, A. R., & Sandborn, W. J. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000173271.18319.53 · Cited by 587
Immunopathology of inflammatory bowel disease
Wallace, K. L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i1.6 · Cited by 579
Consensus Conference: Colorectal Cancer Screening and Surveillance in Inflammatory Bowel Disease
Itzkowitz, S. H., & Present, D. H. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000160811.76729.d5 · Cited by 564
European evidence-based Consensus on the management of ulcerative colitis: Current management
Travis, S. P. L., Stange, E. F., Lémann, M., Øresland, T., Bemelman, W. A., Chowers, Y., Colombel, J. F., D'Haens, G., Ghosh, S., Marteau, P., et al. (2008) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2007.11.002 · Cited by 558
Stange, E. F., Travis, S. P. L., Vermeire, S., Reinisch, W., Geboes, K., Barakauskiene, A., Feakins, R., Fléjou, J. F., Herfarth, H., Hommes, D. W., et al. (2008) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2007.11.001 · Cited by 555
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment
Spinelli, A., Bonovas, S., Burisch, J., Kucharzik, T., Adamina, M., Annese, V., Bachmann, O., Bettenworth, D., Chaparro, M., Czuber-Dochan, W., et al. (2022) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjab177 · Cited by 546
Evidence-based clinical practice guidelines for inflammatory bowel disease 2020
Nakase, H., Uchino, M., Shinzaki, S., Matsuura, M., Matsuoka, K., Kobayashi, T., Saruta, M., Hirai, F., Hata, K., Hiraoka, S., et al. (2021) · Journal of Gastroenterology · doi:10.1007/s00535-021-01784-1 · Cited by 505
An Update on Inflammatory Bowel Disease
Sairenji, T., Collins, K. L., & Evans, D. V. (2017) · Primary Care: Clinics in Office Practice · doi:10.1016/j.pop.2017.07.010 · Cited by 499
Tursi, A., Brandimarte, G., Papa, A., Giglio, A., Elisei, W., Giorgetti, G. M., Forti, G., Morini, S., Hassan, C., Pistoia, M. A., et al. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.218 · Cited by 489
Farraye, F. A., Odze, R. D., Eaden, J., & Itzkowitz, S. H. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.035 · Cited by 494
Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis
Bitton, A., Peppercorn, M. A., Antonioli, D. A., Niles, J. L., Shah, S., Bousvaros, A., Ransil, B., Wild, G., Cohen, A., Deb Edwardes, M. D., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.20912 · Cited by 490
ACG clinical guideline: Preventive care in inflammatory bowel disease
Farraye, F. A., Melmed, G. Y., Lichtenstein, G. R., & Kane, S. V. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.537 · Cited by 473
Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab
Sandborn, W. J., Rutgeerts, P., Feagan, B. G., Reinisch, W., Olson, A., Johanns, J., Lu, J., Horgan, K., Rachmilewitz, D., Hanauer, S. B., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.061 · Cited by 473
The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy
Nguyen, G. C., Seow, C. H., Maxwell, C., Huang, V., Leung, Y., Jones, J., Leontiadis, G. I., Tse, F., Mahadevan, U., van der Woude, C. J., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.12.003 · Cited by 473
An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease
Zhang, S., Ermann, J., Succi, M. D., Zhou, A., Hamilton, M. J., Cao, B., Korzenik, J. R., Glickman, J. N., Vemula, P. K., Glimcher, L. H., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa5657 · Cited by 467
Gut Microbiota and Inflammation
Hakansson, A., & Molin, G. (2011) · Nutrients · doi:10.3390/nu3060637 · Cited by 455
Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions
Peyrin-Biroulet, L., Panés, J., Sandborn, W. J., Vermeire, S., Danese, S., Feagan, B. G., Colombel, J.-F., Hanauer, S. B., & Rycroft, B. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.06.001 · Cited by 455
Burisch, J., Pedersen, N., Čuković-Čavka, S., Brinar, M., Kaimakliotis, I., Duricova, D., Shonová, O., Vind, I., Avnstrøm, S., Thorsgaard, N., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-304636 · Cited by 429
Diagnosis and management of dysplasia in patients with inflammatory bowel diseases
Itzkowitz, S. H., & Harpaz, N. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.025 · Cited by 423
Lichtenstein, G. R., Abreu, M. T., Cohen, R., & Tremaine, W. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.048 · Cited by 417
Bressler, B., Marshall, J. K., Bernstein, C. N., Bitton, A., Jones, J., Leontiadis, G. I., Panaccione, R., Steinhart, A. H., Tse, F., Feagan, B., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.03.001 · Cited by 413
Clinical pharmacology and pharmacogenetics of thiopurines
Sahasranaman, S., Howard, D., & Roy, S. (2008) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-008-0478-6 · Cited by 405
The pattern and outcome of acute severe colitis
Dinesen, L. C., Walsh, A. J., Protic, M. N., Heap, G., Cummings, F., Warren, B. F., George, B., Mortensen, N. J. M., & Travis, S. P. L. (2010) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2010.02.001 · Cited by 403
Feuerstein, J. D., Moss, A. C., & Farraye, F. A. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.01.018 · Cited by 398
Systematic review with meta-analysis: The efficacy of probiotics in inflammatory bowel disease
Derwa, Y., Gracie, D. J., Hamlin, P. J., & Ford, A. C. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14203 · Cited by 393
Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?
Moura, F. A., de Andrade, K. Q., dos Santos, J. C. F., Araújo, O. R. P., & Goulart, M. O. F. (2015) · Redox Biology · doi:10.1016/j.redox.2015.10.006 · Cited by 381
Feuerstein, J. D., & Cheifetz, A. S. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.07.002 · Cited by 376
Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis
Ullman, T., Croog, V., Harpaz, N., Sachar, D., & Itzkowitz, S. (2003) · Gastroenterology · doi:10.1016/j.gastro.2003.08.023 · Cited by 374
Self-citationMahadevan, U., Sandborn, W. J., Li, D., Hakimian, S., Kane, S., & Corley, D. A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.07.019 · Cited by 373
The role of endoscopy in inflammatory bowel disease
Shergill, A. K., Lightdale, J. R., Bruining, D. H., Acosta, R. D., Chandrasekhara, V., Chathadi, K. V., Decker, G. A., Early, D. S., Evans, J. A., Fanelli, R. D., et al. (2015) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2014.10.030 · Cited by 362
Colorectal cancer in inflammatory bowel disease: The risk, pathogenesis, prevention and diagnosis
Kim, E. R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i29.9872 · Cited by 357
Nguyen, G. C., Bernstein, C. N., Bitton, A., Chan, A. K., Griffiths, A. M., Leontiadis, G. I., Geerts, W., Bressler, B., Butzner, J. D., Carrier, M., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.042 · Cited by 350
Biologic agents for IBD: practical insights
Danese, S., Vuitton, L., & Peyrin-Biroulet, L. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.135 · Cited by 342
Tumor Necrosis Factor Inhibitors for Inflammatory Bowel Disease
Nielsen, O. H., & Ainsworth, M. A. (2013) · New England Journal of Medicine · doi:10.1056/nejmct1209614 · Cited by 334
Cancer in inflammatory bowel disease
Xie, J., & Itzkowitz, S. H. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.378 · Cited by 328
Ha, C., Ullman, T. A., Siegel, C. A., & Kornbluth, A. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.02.004 · Cited by 322
Self-citationHanauer, S. B., Sandborn, W. J., Kornbluth, A., Katz, S., Safdi, M., Woogen, S., Regalli, G., Yeh, C., Smith-Hall, N., & Ajayi, F. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.00248.x · Cited by 322
Self-citationGastrointestinal Tract Disorders in Older Age
Dumic, I., Nordin, T., Jecmenica, M., Stojkovic Lalosevic, M., Milosavljevic, T., & Milovanovic, T. (2019) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2019/6757524 · Cited by 314
An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease
Talley, N. J., Abreu, M. T., Achkar, J.-P., Bernstein, C. N., Dubinsky, M. C., Hanauer, S. B., Kane, S. V., Sandborn, W. J., Ullman, T. A., & Moayyedi, P. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.58 · Cited by 310
Colorectal carcinogenesis: Review of human and experimental animal studies
Tanaka, T. (2009) · Journal of Carcinogenesis · doi:10.4103/1477-3163.49014 · Cited by 308
Mow, W. S., Lo, S. K., Targan, S. R., Dubinsky, M. C., Treyzon, L., Abreu-martin, M. T., Papadakis, K. A., & Vasiliauskas, E. A. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(03)00289-1 · Cited by 301
Epidemiology, demographic characteristics and prognostic predictors of ulcerative colitis
Silva, B. C. D., Lyra, A. C., Rocha, R., & Santana, G. O. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i28.9458 · Cited by 297
Colorectal Cancer in Inflammatory Bowel Disease
Higgins, P., & Stidham, R. (2018) · Clinics in Colon and Rectal Surgery · doi:10.1055/s-0037-1602237 · Cited by 295
“53 The American Gastroenter-ological Association (AGA) IBD-CRC surveillance guidelines from 2010 also recommend high-quality colonoscopy with random biopsies, focusing on a high-quality visual examination and facilitating an excellent bowel preparation.”
Efficacy of Upadacitinib in a Randomized Trial of Patients With Active Ulcerative Colitis
Sandborn, W. J., Ghosh, S., Panes, J., Schreiber, S., D’Haens, G., Tanida, S., Siffledeen, J., Enejosa, J., Zhou, W., Othman, A. A., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.02.030 · Cited by 289
Ardizzone, S., Cassinotti, A., Duca, P., Mazzali, C., Penati, C., Manes, G., Marmo, R., Massari, A., Molteni, P., Maconi, G., et al. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.12.028 · Cited by 283
The Epidemiology of Colectomy in Ulcerative Colitis: Results From a Population-Based Cohort
Targownik, L. E., Singh, H., Nugent, Z., & Bernstein, C. N. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.127 · Cited by 280
Role of antibiotics for treatment of inflammatory bowel disease
Nitzan, O. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i3.1078 · Cited by 279
Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer
Feagins, L. A., Souza, R. F., & Spechler, S. J. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.44 · Cited by 274
Eaton, J. E., Silveira, M. G., Pardi, D. S., Sinakos, E., Kowdley, K. V., Luketic, V. A. C., Harrison, E. M., McCashland, T., Befeler, A. S., Harnois, D., et al. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.156 · Cited by 268
Ulcerative colitis-associated colorectal cancer
Yashiro, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i44.16389 · Cited by 267
Diet and nutritional factors in inflammatory bowel diseases
Owczarek, D. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i3.895 · Cited by 263
Randall, J., Singh, B., Warren, B. F., Travis, S. P. L., Mortensen, N. J., & George, B. D. (2010) · British Journal of Surgery · doi:10.1002/bjs.6874 · Cited by 252
Kump, P. K., Gröchenig, H.-P., Lackner, S., Trajanoski, S., Reicht, G., Hoffmann, K. M., Deutschmann, A., Wenzl, H. H., Petritsch, W., Krejs, G. J., et al. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e31829ea325 · Cited by 235
Systematic review with meta-analysis: inflammatory bowel disease in the elderly
Gisbert, J. P., & Chaparro, M. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12616 · Cited by 158
Pérez-Jeldres, T., Tyler, C. J., Boyer, J. D., Karuppuchamy, T., Yarur, A., Giles, D. A., Yeasmin, S., Lundborg, L., Sandborn, W. J., Patel, D. R., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00212 · Cited by 126
Bye, W. A., Ma, C., Nguyen, T. M., Parker, C. E., Jairath, V., & East, J. E. (2018) · American Journal of Gastroenterology · doi:10.1038/s41395-018-0354-7 · Cited by 102
Tricyclic Antidepressants for Management of Residual Symptoms in Inflammatory Bowel Disease
Iskandar, H. N., Cassell, B., Kanuri, N., Gyawali, C. P., Gutierrez, A., Dassopoulos, T., Ciorba, M. A., & Sayuk, G. S. (2014) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000049 · Cited by 96
Parra, R. S., Chebli, J. M., Amarante, H. M., Flores, C., Parente, J. M., Ramos, O., Fernandes, M., Rocha, J. J., Feitosa, M. R., Feres, O., et al. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i38.5862 · Cited by 92
Psychosocial issues in evidence-based guidelines on inflammatory bowel diseases: A review
Häuser, W. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i13.3663 · Cited by 70
Clinical course of ulcerative colitis in patients with and without primary sclerosing cholangitis
MOAYYERI, A., DARYANI, N. E., BAHRAMI, H., HAGHPANAH, B., NAYYER‐HABIBI, A., & SADATSAFAVI, M. (2005) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2005.03727.x · Cited by 60
Sartor, R. B. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13436 · Cited by 60
Gut microbiota and inflammatory bowel disease: the role of antibiotics in disease management
Kerman, D. H., & Deshpande, A. R. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.07.2779 · Cited by 47
Lee, J.-G., Lee, S., Jeon, J., Kong, H. G., Cho, H.-J., Kim, J.-H., Kim, S.-Y., Oh, M. J., Lee, D., Seo, N., et al. (2022) · Microbiome · doi:10.1186/s40168-021-01191-x · Cited by 26
Three initial diets for management of mild acute pancreatitis: A meta-analysis
Meng, W.-B. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i37.4235 · Cited by 26
Shimizu, T., Kijima, A., Masuo, Y., Ishimoto, T., Sugiura, T., Takahashi, S., Nakamichi, N., & Kato, Y. (2015) · Biological & Pharmaceutical Bulletin · doi:10.1248/bpb.b15-00109 · Cited by 8
Metadata
- Authors
- Kornbluth, A., & Sachar, D. B.
- Venue
- American Journal of Gastroenterology
- Published
- 2010-03
- Volume
- 105
- Issue
- 3
- Pages
- 501-523
- ISSN
- 0002-9270 (ISSN-L)
- OpenAlex
- W4295333203
- Cited by
- 2,023
- References
- 326
- FWCI
- 71.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.